MicroRNA-29b-3p reduces cisplatin resistance in non-small cell lung cancer by targeting myeloid cell leukemia-1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNA-29b-3p reduces cisplatin resistance in non-small cell lung cancer by targeting myeloid cell leukemia-1

Published:2024-04-12 Issue: Volume: Page:
ISSN:1738-642X
Container-title:Molecular & Cellular Toxicology
language:en
Short-container-title:Mol. Cell. Toxicol.

Author:

Cheng Yuanjun,Chen Bin,Dong Xuxiao,Shu Jian,Yao Jie^ORCID

Funder

Key research and Development Program of Anhui Province in 2021

Beijing Science and Technology Innovation Medical Development Foundation

Guiding project of Suzhou Science and Technology Development Plan

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13273-024-00438-6.pdf

Reference35 articles.

1. Akagi H, Higuchi H, Sumimoto H, Igarashi T, Kabashima A, Mizuguchi H, Izumiya M, Sakai G, Adachi M, Funakoshi S, Nakamura S, Hamamoto Y, Kanai T, Takaishi H, Kawakami Y, Hibi T (2013) Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer 16:100

2. Al-Odat O, von Suskil M, Chitren R, Elbezanti W, Srivastava S, Budak-Alpddogan T, Jonnalagadda S, Aggarwal B, Pandey M (2021) Mcl-1 inhibition: managing malignancy in multiple myeloma. Front Pharmacol 12:699629

3. Belmar J, Fesik SW (2015) Small molecule Mcl-1 inhibitors for the treatment of cancer. Pharmacol Ther 145:76

4. Cao F, Gong YB, Kang XH, Lu ZH, Wang Y, Zhao KL, Miao ZH, Liao MJ, Xu ZY (2019) Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer. Toxicol Appl Pharmacol 379:114662

5. Che F, Ye X, Wang Y, Ma S, Wang X (2021) Lnc NEAT1/miR-29b-3p/Sp1 form a positive feedback loop and modulate bortezomib resistance in human multiple myeloma cells. Eur J Pharmacol 891:173752

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3